Standout Papers

Pembrolizumab monotherapy... 2021 2026 2022 2024 2021 100 200 300

Immediate Impact

5 by Nobel laureates 64 hit
Sub-graph 1 of 20

Citing Papers

Therapy-induced senescent cancer cells contribute to cancer progression by promoting ribophorin 1-dependent PD-L1 upregulation
2025 Hit
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
2024 Hit
4 intermediate papers

Works of Kijoeng Nam being referenced

Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
2021 Hit
KEYNOTE-676: Phase III study of BCG and pembrolizumab for persistent/recurrent high-risk NMIBC
2020
and 1 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kijoeng Nam 521 237 120 99 81 22 600
Ekta Kapadia 506 1.0× 223 0.9× 120 1.0× 101 1.0× 83 1.0× 24 572
Laurence E. Krieger 441 0.8× 213 0.9× 109 0.9× 83 0.8× 91 1.1× 25 513
José Portillo 586 1.1× 144 0.6× 72 0.6× 186 1.9× 69 0.9× 18 641
Nicolás Flores 487 0.9× 98 0.4× 92 0.8× 197 2.0× 62 0.8× 21 613
Armine K. Smith 415 0.8× 90 0.4× 73 0.6× 171 1.7× 125 1.5× 26 532
Ashish M. Kamat 536 1.0× 107 0.5× 88 0.7× 173 1.7× 99 1.2× 14 568
Takayuki Toyonaga 389 0.7× 165 0.7× 60 0.5× 45 0.5× 106 1.3× 18 521
Oddvar Mestad 602 1.2× 110 0.5× 57 0.5× 257 2.6× 53 0.7× 14 634
Justine Varinot 382 0.7× 109 0.5× 102 0.8× 120 1.2× 174 2.1× 39 612
Christoph Ausch 236 0.5× 251 1.1× 209 1.7× 44 0.4× 99 1.2× 29 659

All Works

Loading papers...

Rankless by CCL
2026